VNRX insider transaction filings
VOLITIONRX LTD — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-19. Screen VNRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-19 | 4 | Plummer Nicholas — GC - Volition Diagnostics | Tax withholding (F): 7,003 @ $0.19 | EDGAR |
| 2026-03-19 | 4 | Forterre Gael — Chief Commercial Officer | Tax withholding (F): 5,251 @ $0.19 | EDGAR |
| 2026-03-19 | 4 | Micallef Jacob Vincent — Chief Scientific Officer | Tax withholding (F): 5,310 @ $0.19 | EDGAR |
| 2026-03-19 | 4 | Rootsaert Rodney Gerard — Secretary | Tax withholding (F): 3,948 @ $0.19 | EDGAR |
| 2026-03-03 | 4 | Plummer Nicholas — GC - Volition Diagnostics | Tax withholding (F): 5,867 @ $0.21 | EDGAR |
| 2026-03-03 | 4 | Forterre Gael — Chief Commercial Officer | Tax withholding (F): 2,283 @ $0.21 | EDGAR |
| 2026-03-03 | 4 | Rootsaert Rodney Gerard — Secretary | Tax withholding (F): 3,321 @ $0.21 | EDGAR |
| 2026-02-27 | 4 | Rubin Ethel — Director | Grant/award (A): 178,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Batchelor Ann-Louise — Group Chief Marketing Officer | Grant/award (A): 142,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Plummer Nicholas — GC - Volition Diagnostics | Grant/award (A): 187,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Nguyen Kim — Director | Grant/award (A): 178,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Forterre Gael — Chief Commercial Officer | Grant/award (A): 149,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Hughes Terig — Chief Financial Officer | Grant/award (A): 202,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Kway Jasmine — CEO - Singapore Volition | Grant/award (A): 173,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Micallef Jacob Vincent — Chief Scientific Officer | Grant/award (A): 149,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Innes Guy Archibald — Director | Grant/award (A): 178,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Rootsaert Rodney Gerard — Secretary | Grant/award (A): 119,000 @ $0 | EDGAR |
| 2026-02-27 | 4 | Reynolds Cameron John — President and CEO, Director | Grant/award (A): 486,000 @ $0 | EDGAR |
| 2026-02-03 | 4 | Plummer Nicholas — GC - Volition Diagnostics | Tax withholding (F): 5,647 @ $0.28 | EDGAR |
| 2026-02-03 | 4 | Forterre Gael — Chief Commercial Officer | Tax withholding (F): 2,010 @ $0.28 | EDGAR |
| 2026-02-03 | 4 | Rootsaert Rodney Gerard — Secretary | Tax withholding (F): 3,196 @ $0.28 | EDGAR |
| 2026-01-23 | 4 | Rubin Ethel — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Batchelor Ann-Louise — Group Chief Marketing Officer | Grant/award (A): 33,900 @ $0 | EDGAR |
| 2026-01-23 | 4 | Henshall Mickie — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Plummer Nicholas — GC - Volition Diagnostics | Grant/award (A): 44,700 @ $0 | EDGAR |
| 2026-01-23 | 4 | Nguyen Kim — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Forterre Gael — Chief Commercial Officer | Grant/award (A): 38,100 @ $0 | EDGAR |
| 2026-01-23 | 4 | Hughes Terig — Chief Financial Officer | Grant/award (A): 49,200 @ $0 | EDGAR |
| 2026-01-23 | 4 | Butera Salvatore Thomas — CEO - Volition Veterinary | Grant/award (A): 53,400 @ $0 | EDGAR |
| 2026-01-23 | 4 | Kway Jasmine — CEO - Singapore Volition | Grant/award (A): 42,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Barnes Phillip — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Micallef Jacob Vincent — Chief Scientific Officer | Grant/award (A): 35,400 @ $0 | EDGAR |
| 2026-01-23 | 4 | Innes Guy Archibald — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Rootsaert Rodney Gerard — Secretary | Grant/award (A): 28,200 @ $0 | EDGAR |
| 2026-01-23 | 4 | Colman Alan — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Reynolds Cameron John — President and CEO, Director | Grant/award (A): 74,700 @ $0 | EDGAR |
| 2026-01-23 | 4 | STILL TIMOTHY I — Director | Grant/award (A): 90,000 @ $0 | EDGAR |
| 2025-11-17 | 4 | Reynolds Cameron John — President and CEO, Director | Purchase (P): 20,000 @ $0.35 | EDGAR |
| 2025-11-04 | 4 | Retter Andrew — Chief Medical Officer | Tax withholding (F): 4,588 @ $0.43 | EDGAR |
| 2025-11-04 | 4 | Plummer Nicholas — GC - Volition Diagnostics | Tax withholding (F): 5,647 @ $0.43 | EDGAR |
| 2025-11-04 | 4 | Forterre Gael — Chief Commercial Officer | Tax withholding (F): 1,753 @ $0.43 | EDGAR |
| 2025-11-04 | 4 | Butera Salvatore Thomas — CEO - Volition Veterinary | Tax withholding (F): 4,648 @ $0.43 | EDGAR |
| 2025-11-04 | 4 | Rootsaert Rodney Gerard — Secretary | Tax withholding (F): 3,197 @ $0.43 | EDGAR |
| 2025-10-15 | 4 | Innes Guy Archibald — Director | Purchase (P): 96,153 @ $0.51 · Purchase (P): 96,153 (derivative) @ $0.01 | EDGAR |
| 2025-10-15 | 4 | Reynolds Cameron John — President and CEO, Director | Purchase (P): 110,000 @ $0.51 · Purchase (P): 110,000 (derivative) @ $0.01 | EDGAR |
| 2025-10-15 | 4 | STILL TIMOTHY I — Director | Purchase (P): 48,076 @ $0.51 · Purchase (P): 48,076 (derivative) @ $0.01 | EDGAR |
| 2025-10-07 | 4 | Batchelor Ann-Louise — Group Chief Marketing Officer | Tax withholding (F): 6,110 @ $0.65 | EDGAR |
| 2025-10-07 | 4 | Plummer Nicholas — GC - Volition Diagnostics | Tax withholding (F): 8,146 @ $0.65 | EDGAR |
| 2025-10-07 | 4 | Forterre Gael — Chief Commercial Officer | Tax withholding (F): 5,389 @ $0.65 | EDGAR |
| 2025-10-07 | 4 | Butera Salvatore Thomas — CEO - Volition Veterinary | Tax withholding (F): 5,834 @ $0.65 | EDGAR |
Recent 8-K events — VOLITIONRX LTD
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-07-21 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-06-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-05-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VNRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →